Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    20304499 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: CF101;   Drug: Placebo
2 Completed Trial of CF101 to Treat Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: CF101

Indicates status has not been verified in more than two years